CA2755833A1 - Countermeasure methods and devices - Google Patents

Countermeasure methods and devices Download PDF

Info

Publication number
CA2755833A1
CA2755833A1 CA2755833A CA2755833A CA2755833A1 CA 2755833 A1 CA2755833 A1 CA 2755833A1 CA 2755833 A CA2755833 A CA 2755833A CA 2755833 A CA2755833 A CA 2755833A CA 2755833 A1 CA2755833 A1 CA 2755833A1
Authority
CA
Canada
Prior art keywords
toxic agents
derivative
chitosan
topical formulation
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2755833A
Other languages
English (en)
French (fr)
Inventor
W. Gregory Kenton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2755833A1 publication Critical patent/CA2755833A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CA2755833A 2009-03-19 2010-03-19 Countermeasure methods and devices Abandoned CA2755833A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16150009P 2009-03-19 2009-03-19
US61/161,500 2009-03-19
PCT/US2010/027984 WO2010108098A1 (en) 2009-03-19 2010-03-19 Countermeasure methods and devices

Publications (1)

Publication Number Publication Date
CA2755833A1 true CA2755833A1 (en) 2010-09-23

Family

ID=42740014

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2755833A Abandoned CA2755833A1 (en) 2009-03-19 2010-03-19 Countermeasure methods and devices

Country Status (4)

Country Link
US (1) US20120010167A1 (enExample)
JP (1) JP2012521357A (enExample)
CA (1) CA2755833A1 (enExample)
WO (1) WO2010108098A1 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04334321A (ja) * 1991-05-09 1992-11-20 Unitika Ltd 皮膚炎症予防剤
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
DE19810094A1 (de) * 1998-03-10 1999-09-16 Nukem Nuklear Gmbh Adsorptionsmittel für Radionuklide
FR2805465B1 (fr) * 2000-02-28 2003-02-21 Medecine Information Formation Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
JP2002179578A (ja) * 2000-12-14 2002-06-26 Noevir Co Ltd 高分子化抗酸化剤、及びこれを含有する皮膚外用剤

Also Published As

Publication number Publication date
JP2012521357A (ja) 2012-09-13
US20120010167A1 (en) 2012-01-12
WO2010108098A1 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
WO2008016475A3 (en) Immune response modifier compositions and methods
UA104320C2 (ru) Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии
WO2006125092A3 (en) Treatment device and method for treating skin lesions through application of heat
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
MX2009003504A (es) Dispositivo para suministro local y/o regional que utiliza formulaciones liquidas de agentes terapeuticos.
WO2009078447A1 (ja) 抗ノロウイルス剤、抗インフルエンザウイルス剤、およびこれらを用いた抗ウイルス処理方法
WO2011051633A3 (fr) Utilisation d'un extrait de punica granatum pour lutter contre la canitie
ATE529417T1 (de) 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält
WO2010111640A3 (en) Anti-influenza formulations and methods
WO2007121088A3 (en) Combinations of therapeutic agents for treating cancer
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
WO2006078424A3 (en) Polyherbal compositions and methods for treating viral infections
IL173852A0 (en) High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
MX2009004692A (es) Composicion para el tratamiento de afecciones de la piel.
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
MX335951B (es) Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades.
EA201390345A1 (ru) Терапевтическое болеутоляющее средство
EP1639971A4 (en) COMPOSITIONS FOR SKIN PROTECTION
CA2755833A1 (en) Countermeasure methods and devices
EP1753425A4 (en) THERAPEUTIC AGENT COMPRISING A NICOTINIC ACID OR DERIVATIVES AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF CANCER
MX2009006311A (es) Terapia de combinacion para tratar infecciones de hepatitis c.
US9744125B2 (en) Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses
AU2002333535A1 (en) Treatment of excessive radiation (e.g. sunburn) exposure
MX2012006217A (es) Derivados de peroxido nuevos, su proceso de preparacion y su uso en medicina humana y en cosmeticos para el tratamiento o prevencion de acne.
EP4366753B8 (en) Use of a vegetal extract from salvia haenkei as an active agent in the treatment of heart diseases

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140319